Polycystic ovarian disease: animal models.
The reproductive systems of human beings and other vertebrates are grossly similar. In the ovary particularly, the biochemical and physiologic processes are identical not only in the formation of germ cells, the development of primordial follicles and their subsequent growth to Graafian follicles, and eventual ovulation but also in anatomic structure. In a noncarcinogenic human ovary, hypersecretion of androgen causes PCOD. Such hypersecretion may result from a nonpulsatile, constant elevated level of circulating LH or a disturbance in the action of neurotransmitters in the hypothalamus. In studying the pathophysiology of PCOD in humans, one must be aware of the limitations for manipulating the hypothalamic-pituitary axis. Although the rat is a polytocous rodent, the female has a regular ovarian cyclicity of 4 or 5 days, with distinct proestrus, estrus, and diestrus phases. Inasmuch as PCOD can be experimentally produced in the rat, that species is a good model for studying the pathophysiology of human PCOD. These PCOD models and their validity have been described: (1) estradiol-valerate, (2) DHA, (3) constant-light (LL), and (4) neonatally androgenized. Among these, the LL model is noninvasive and seems superior to the others for study of the pathophysiology of PCOD. The production of the polycystic ovarian condition in the rat by the injection of estrogens or androgens in neonate animals, or estradiol or DHA in adult rats, or the administration of antigonadotropins to these animals all cause a sudden appearance of the persistent estrus state by disturbing the metabolic and physiologic processes, whereas exposure of the adult rat to LL causes polycystic ovaries gradually, similar to what is seen in human idiopathic PCOD. After about 50 days of LL, the rat becomes anovulatory and the ovaries contain thickened tunica albuginea and many atretic follicles, and the tertiary follicles are considerably distended and cystic. The granulosa and theca cells appear normal histologically, although some of the stromal cells appear hypertrophic. The anatomic features consequent to polycystic ovaries resulting from LL are similar to those in human PCOD, and both rat and human PCOD ovarian cells still retain the ability to respond to FSH/LH, LHRH, and unilateral ovariectomy. In the estradiol valerate rat model, although the anatomy and physiology of the ovary resemble those of PCOD patients, the progressive degeneration of the hypothalamus and the altered response of the pituitary to LHRH make this model inappropriate for studying the hypothalamic-pituitary-ovarian axis in the polycystic ovary condition.(ABSTRACT TRUNCATED AT 400 WORDS)
Mahajan
D K
DK
Department of Obstetrics and Gynecology, Louisiana State University School of Medicine, New Orleans.
D000818:Animals; D003687:Dehydroepiandrosterone; D004195:Disease Models, Animal; D004723:Endorphins / Q000502:physiology; D004958:Estradiol / Q000031:analogs & derivatives; D005260:Female; D007031:Hypothalamus / Q000503:physiopathology; D008027:Light; D007986:Luteinizing Hormone / Q000378:metabolism; D008253:Macaca mulatta; D010053:Ovary / Q000473:pathology / Q000503:physiopathology; D010902:Pituitary Gland / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D013256:Steroids / Q000502:physiology
D004723:Endorphins; D013256:Steroids; D003687:Dehydroepiandrosterone; D004958:Estradiol; D007986:Luteinizing Hormone